Cisplatin Based Chemoradiation Late Toxicities in Head and Neck Squamous Cell Carcinoma Patients

Nenhuma Miniatura disponível
Citações na Scopus
30
Tipo de produção
article
Data de publicação
2015
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
DISCOVERY MEDICINE
Autores
Citação
DISCOVERY MEDICINE, v.108, p.57-66, 2015
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: Cisplatin-based chemoradiation (CRT) offers head and neck squamous cell carcinoma (HNSCC) patients better overall survival when compared to radiation alone. However, it also increases acute and late toxicity (LT). Here we aimed to review the main aspects of diagnosis and treatment of long-term toxicities in HNSCC patients after CRT. Methods: We crossed-searched PubMed MeshTerms: Survivors, Deglutition Disorders, Xerostomia, Hypothyroidism, Cisplatin, Kidney, Hearing, and Osteoradionecrosis, with keywords: ""Head and Neck Neoplasms"" and ""Chemoradiotherapy."" A total of 5,541 publications were retrieved and 48 were selected for this systematic review. Results: Dysphagia (25%), xerostomia (40-80%, depending on the technique used), hypothyroidism (42%), ototoxicity (27%), and osteoradionecrosis (4%) were the most commonly reported LT and were related to compromised quality of life aspects in HNSCC patients. Concurrent cisplatin and higher radiation doses, especially to normal tissue, increased the rates of LT. Conclusions: Late CRT toxicities were reported mostly in retrospective studies. Addressing these adverse effects as endpoints in future clinical trials is necessary to provide tools to prevent and treat them adequately, allowing better quality of life and survival results.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/12830
Referências
  1. Aich Ranen Kanti, 2005, J Cancer Res Ther, V1, P142
  2. Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217
  3. Dornfeld K, 2007, INT J RADIAT ONCOL, V68, P750, DOI 10.1016/j.ijrobp.2007.01.047
  4. Schwarz E, 1999, J DENT, V27, P21, DOI 10.1016/S0300-5712(98)00024-4
  5. Parkin DM, 2005, CA-CANCER J CLIN, V55, P74
  6. Wilson JA, 2011, OTOLARYNG HEAD NECK, V145, P767, DOI 10.1177/0194599811414506
  7. Bensadoun RJ, 2006, INT J RADIAT ONCOL, V64, P983, DOI 10.1016/j.ijrobp.2005.09.041
  8. Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4
  9. Wang RS, 2013, J CANCER RES CLIN, V139, P139, DOI 10.1007/s00432-012-1313-0
  10. Schuurhuis JM, 2011, RADIOTHER ONCOL, V101, P403, DOI 10.1016/j.radonc.2011.09.018
  11. Bhandare N, 2007, INT J RADIAT ONCOL, V68, P1131, DOI 10.1016/j.ijrobp.2007.01.029
  12. Denis F, 2004, J CLIN ONCOL, V22, P69, DOI 10.1200/JCO.2004.08.021
  13. Dirix P, 2008, SUPPORT CARE CANCER, V16, P171, DOI 10.1007/s00520-007-0300-5
  14. Wu Y, 2007, QUAL LIFE RES, V16, P65, DOI 10.1007/s11136-006-9113-0
  15. Campbell BH, 2004, ARCH OTOLARYNGOL, V130, P1100, DOI 10.1001/archotol.130.9.1100
  16. Vlacich G, 2014, RADIOTHER ONCOL, V110, P435, DOI 10.1016/j.radonc.2013.12.007
  17. Fang FM, 2007, CANCER, V109, P313, DOI 10.1002/cncr.22396
  18. Semrau R, 2006, INT J RADIAT ONCOL, V64, P1308, DOI 10.1016/j.ijrobp.2005.10.039
  19. Olmi P, 2003, INT J RADIAT ONCOL, V55, P78, DOI 10.1016/S0360-3016(02)03792-6
  20. Miah AB, 2013, RADIOTHER ONCOL, V106, P346, DOI 10.1016/j.radonc.2013.03.006
  21. Tsai CJ, 2013, INT J RADIAT ONCOL, V85, P415, DOI 10.1016/j.ijrobp.2012.05.032
  22. Eisbruch A, 2004, INT J RADIAT ONCOL, V60, P1425, DOI 10.1016/j.ijrobp.2004.05.050
  23. Machtay M, 2012, INT J RADIAT ONCOL, V84, P983, DOI 10.1016/j.ijrobp.2012.03.005
  24. Machtay M, 2008, J CLIN ONCOL, V26, P3582, DOI 10.1200/JCO.2007.14.8841
  25. Hunter KU, 2014, HEAD NECK-J SCI SPEC, V36, P120, DOI 10.1002/hed.23275
  26. Nutting CM, 2011, LANCET ONCOL, V12, P127, DOI 10.1016/S1470-2045(10)70290-4
  27. Low WK, 2006, J CLIN ONCOL, V24, P1904, DOI 10.1200/JCO.2005.05.0096
  28. Dell'Aringa AHB, 2010, BRAZ J OTORHINOLAR, V76, P527, DOI 10.1590/S1808-86942010000400019
  29. Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014
  30. Boomsma MJ, 2012, INT J RADIAT ONCOL, V84, pE351, DOI 10.1016/j.ijrobp.2012.05.020
  31. Lee IJ, 2009, INT J RADIAT ONCOL, V75, P1084, DOI 10.1016/j.ijrobp.2008.12.052
  32. Tell R, 2004, INT J RADIAT ONCOL, V60, P395, DOI 10.1016/j.ijrobp.2004.03.020
  33. Feng FY, 2007, INT J RADIAT ONCOL, V68, P1289, DOI 10.1016/j.ijrobp.2007.02.049
  34. Zuur CL, 2007, INT J RADIAT ONCOL, V68, P1320, DOI 10.1016/j.ijropb.2007.01.042
  35. Givens DJ, 2009, ARCH OTOLARYNGOL, V135, P1209, DOI 10.1001/archoto.2009.174
  36. Caglar HB, 2008, INT J RADIAT ONCOL, V72, P1110, DOI 10.1016/j.ijrobp.2008.02.048
  37. van der Molen L, 2013, RADIOTHER ONCOL, V106, P364, DOI 10.1016/j.radonc.2013.03.005
  38. Brizel DM, 1998, NEW ENGL J MED, V338, P1798, DOI 10.1056/NEJM199806183382503
  39. Mini S, 2001, CANCER, V92, P1512, DOI 10.1002/1097-0142(20010915)92:6<1512::AID-CNCR1476>3.0.CO;2-X
  40. Wendt TG, 1998, J CLIN ONCOL, V16, P1318
  41. Gomez DR, 2011, INT J RADIAT ONCOL, V81, pE207, DOI 10.1016/j.ijrobp.2011.02.003
  42. Rogus-Pulia NM, 2014, DYSPHAGIA, V29, P223, DOI 10.1007/s00455-013-9500-y
  43. Calais G, 1999, J NATL CANCER I, V91, P2081, DOI 10.1093/jnci/91.24.2081
  44. Nguyen NP, 2012, ORAL ONCOL, V48, P653, DOI 10.1016/j.oraloncology.2012.01.016
  45. Ronjom MF, 2013, RADIOTHER ONCOL, V109, P317, DOI 10.1016/j.radonc.2013.06.029
  46. Budach V, 2005, J CLIN ONCOL, V23, P1125, DOI 10.1200/JCO.2005.07.010
  47. Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786
  48. Launay-Vacher V, 2010, SEMIN NEPHROL, V30, P548, DOI 10.1016/j.semnephrol.2010.09.003
  49. Banipal RPS, 2011, INDIAN J CANCER, V48, P194, DOI 10.4103/0019-509X.82886
  50. Mittal BB, 2003, INT J RADIAT ONCOL, V57, P1219, DOI 10.1016/S0360-3016(03)01454-8
  51. Dirix P, 2006, CANCER, V107, P2525, DOI 10.1002/cncr.22302
  52. Francis DO, 2010, ANN OTO RHINOL LARYN, V119, P391
  53. Little M, 2012, INT J RADIAT ONCOL, V83, P1007, DOI 10.1016/j.ijrobp.2011.09.004
  54. Baujat B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002026
  55. Bernat L, 2014, J CRANIO MAXILL SURG, V42, P356, DOI 10.1016/j.jcms.2013.09.009
  56. Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0
  57. Mathe C, 2011, EUR RESPIR J, V37, P888, DOI 10.1183/09031936.00055110
  58. de Castro G, 2007, EUR ARCH OTO-RHINO-L, V264, P1475, DOI 10.1007/s00405-007-0395-9
  59. de Castro Gilberto Jr, 2006, Curr Opin Oncol, V18, P266, DOI 10.1097/01.cco.0000219256.37843.83
  60. Hanigan M. H., 2003, CANC THERAPY, V1, P47
  61. McBride SM, 2014, HEAD NECK-J SCI SPEC, V36, P492, DOI 10.1002/hed.23319
  62. Miller MC, 2009, CURR OPIN OTOLARYNGO, V17, P111, DOI 10.1097/MOO.0b013e328325a538
  63. Murono S, 2015, SUPPORT CARE CANCER, V23, P457, DOI 10.1007/s00520-014-2388-8
  64. Paleri V, 2014, HEAD NECK-J SCI SPEC, V36, P431, DOI 10.1002/hed.23251
  65. Petsuksiri J, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-19
  66. Rybak Leonard P, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P364, DOI 10.1097/MOO.0b013e3282eee452
  67. Sankaranarayanan R, 1998, ANTICANCER RES, V18, P4779
  68. Setton J, 2015, CANCER-AM CANCER SOC, V121, P294, DOI 10.1002/cncr.29022
  69. Srikantia Nirmala, 2011, Indian J Med Paediatr Oncol, V32, P143, DOI 10.4103/0971-5851.92813
  70. Theunissen EAR, 2014, LARYNGOSCOPE, V124, P2720, DOI 10.1002/lary.24802
  71. van den Berg MGA, 2014, HEAD NECK-J SCI SPEC, V36, P60, DOI 10.1002/hed.23265
  72. Wijers OB, 2002, HEAD NECK-J SCI SPEC, V24, P737, DOI 10.1002/hed.10129

Coleções
Artigos e Materiais de Revistas Científicas - HC/ICESP
Artigos e Materiais de Revistas Científicas - LIM/24
Artigos e Materiais de Revistas Científicas - ODS/03